ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer

Lora Stojanovic1,2, Rachel Abbotts1,2, Kaushelendra Tripathi1,2

  • 1University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland.

Cancer Research
|January 13, 2025
PubMed

Insights

DNA methyltransferase (DNMT) and PARP inhibitors upregulate ZNFX1, a protein that triggers a pathogen mimicry response (PMR). ZNFX1 acts as a tumor suppressor in ovarian cancer, potentially serving as a biomarker for personalized therapy.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • DNA methyltransferase (DNMT) and PARP inhibitors can induce a pathogen mimicry response (PMR) in various cancers.
  • This response is dependent on the stimulator of IFN genes (STING).

Purpose of the Study:

  • To investigate the role of ZNFX1 in mediating the PMR induced by DNMT and PARP inhibitors.
  • To explore ZNFX1's function as a tumor suppressor in ovarian cancer and its potential as a therapeutic biomarker.

Main Methods:

  • Combining DNMT and PARP inhibitors in cancer cells.
  • Assessing ZNFX1 protein expression and its role in signaling pathways.
  • In vitro and in vivo functional assays to evaluate ZNFX1's impact on cancer cell proliferation and tumor growth.
  • Analysis of patient ovarian cancer databases and clinical trial data.

Main Results:

  • Combined DNMT and PARP inhibition upregulated ZNFX1 expression.
  • ZNFX1 mediated PMR through mitochondria, acting as a gateway for STING-dependent IFN/inflammasome signaling.
  • Loss of ZNFX1 promoted ovarian cancer cell proliferation, spheroid formation, and tumor growth.
  • Elevated ZNFX1 expression correlated with advanced disease but also with increased survival in therapy-resistant ovarian cancer patients.
  • ZNFX1 signaling was associated with abnormal vasculogenesis.

Conclusions:

  • ZNFX1 is a tumor suppressor that regulates mitochondrial PMR signaling.
  • ZNFX1 acts as a crucial mediator in the STING-dependent inflammasome pathway.
  • ZNFX1 may serve as a valuable biomarker for personalized therapeutic strategies in ovarian cancer.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K